Thromboembolic and cardiovascular risk in rheumatoid arthritis: role of the haemostatic system
Authors:
- 1 June 2014
- journal article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 73 (6) , 954-957
Abstract
Circumstantial evidence suggests that the innate immune system and coagulation system share a common evolutionary origin, which explains the extensive crosstalk between inflammatory cytokines and coagulation factors, with many components being important for both systems. This crosstalk has been extensively studied in sepsis, an acute state of high-grade inflammation. However, rheumatoid arthritis (RA) as well as many other autoimmune diseases can also be considered as a prothrombotic state. More and more studies show that autoimmune diseases, including RA, are a risk factor for cardiovascular disease, and also for venous thromboembolic events, such as pulmonary embolism and deep vein thrombosis. Inflammation and its effect on the haemostatic system is probably the link between these diseases. This viewpoint gives an update of the current literature on thromboembolic risk in RA, but also documents important knowledge gaps. This viewpoint will therefore help to focus on further research topics to improve diagnostic and therapeutic options which may relieve both the proinflammatory and the prothrombotic burden of autoimmune diseases.Keywords
This publication has 29 references indexed in Scilit:
- A practical guide to the monitoring and management of the complications of systemic corticosteroid therapyAllergy, Asthma & Clinical Immunology, 2013
- Early Vascular Alterations in SLE and RA Patients—A Step towards Understanding the Associated Cardiovascular RiskPLOS ONE, 2012
- Noncardiac vascular disease in rheumatoid arthritis: Increase in venous thromboembolic events?Arthritis & Rheumatism, 2011
- Non‐steroidal anti‐inflammatory drug use and risk of venous thromboembolismJournal of Thrombosis and Haemostasis, 2011
- Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritisRheumatology, 2011
- Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage studyBMC Medicine, 2011
- Cardiovascular Morbidity and Mortality in Rheumatoid ArthritisThe American Journal of Medicine, 2008
- C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferationCardiovascular Research, 2005
- Coagulation inhibitors in inflammationBiochemical Society Transactions, 2005
- The relationship between inflammation and venous thrombosisThrombosis and Haemostasis, 2005